Yet the National Diabetes Audit (NDA) demonstrates slow and unequal progress in uptake of insulin pumps; around 90,000 people who meet NICE criteria are not prescribed insulin pumps (NDA) [6]. This evidence concerns the gene INS and diabetes mellitus.